Synthesis and characterization of 64 Cu-labeled Geldanamycin derivative for imaging HSP90 expression in breast cancer.

MLA

Li, Feng, et al. “Synthesis and Characterization of 64 Cu-Labeled Geldanamycin Derivative for Imaging HSP90 Expression in Breast Cancer.” Nuclear Medicine and Biology, vol. 136–137, Sept. 2024, p. 108929. EBSCOhost, https://doi.org/10.1016/j.nucmedbio.2024.108929.

APA

Li, F., Fan, Y., Zhou, L., Martin, D. R., Liu, Z., & Li, Z. (2024). Synthesis and characterization of 64 Cu-labeled Geldanamycin derivative for imaging HSP90 expression in breast cancer. Nuclear Medicine and Biology, 136–137, 108929. https://doi.org/10.1016/j.nucmedbio.2024.108929

Chicago

Li, Feng, Yubo Fan, Lan Zhou, Diego R Martin, Zhonglin Liu, and Zheng Li. 2024. “Synthesis and Characterization of 64 Cu-Labeled Geldanamycin Derivative for Imaging HSP90 Expression in Breast Cancer.” Nuclear Medicine and Biology 136–137 (September): 108929. doi:10.1016/j.nucmedbio.2024.108929.